Takeda Pharmaceutical Co. Ltd.'s new alliance with the US startup PvP Biologics appears clearly designed to further strengthen the Japanese company's presence in the gastrointestinal area, one of its core therapeutic fields along with oncology and CNS.
The celiac disease-focused collaboration also represents an early big win for PvP, a university spin-out formed in 2012 that could...